TMDIF vs. RCEL, NYXH, MBOT, LNSR, LAKE, SPAI, PROF, INO, LUCD, and HYPR
Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Avita Medical (RCEL), Nyxoah (NYXH), Microbot Medical (MBOT), LENSAR (LNSR), Lakeland Industries (LAKE), Safe Pro Group (SPAI), Profound Medical (PROF), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.
Titan Medical vs. Its Competitors
Avita Medical (NASDAQ:RCEL) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.
In the previous week, Avita Medical had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Avita Medical and 0 mentions for Titan Medical. Avita Medical's average media sentiment score of 0.45 beat Titan Medical's score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.
Titan Medical has a net margin of 0.00% compared to Avita Medical's net margin of -68.87%. Titan Medical's return on equity of -82.31% beat Avita Medical's return on equity.
Avita Medical presently has a consensus target price of $11.60, suggesting a potential upside of 117.64%. Given Avita Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Avita Medical is more favorable than Titan Medical.
27.7% of Avita Medical shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Titan Medical has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Avita Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.
Summary
Avita Medical beats Titan Medical on 9 of the 16 factors compared between the two stocks.
Get Titan Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TMDIF vs. The Competition
Titan Medical Competitors List
Related Companies and Tools
This page (NASDAQ:TMDIF) was last updated on 9/25/2025 by MarketBeat.com Staff
Free TMDIF Stock Alerts